Local Anesthetic Ropivacaine Exhibits Therapeutic Effects in Cancers

Area of Science:

• Oncology
• Pharmacology
• Drug Discovery

Background:

• Cancer treatment requires novel therapeutics due to resistance and limitations of current drugs.
• Drug repurposing offers a viable strategy for identifying new anticancer agents from existing medications.

Purpose of the Study:

• To review the past decade of research on ropivacaine's anticancer effects.
• To explore ropivacaine's potential in cancer treatment and as a sensitizer for conventional chemotherapeutics.
• To interpret the underlying mechanisms of ropivacaine's anticancer activity.

Main Methods:

• Literature review of in vitro and in vivo studies on ropivacaine in cancer.
• Analysis of ropivacaine's reported mechanisms of action.
• Synthesis of findings to assess its therapeutic potential.

Main Results:

• Ropivacaine exhibits anticancer activity and sensitizing effects on cancer cells, both in vitro and in vivo.
• Identified mechanisms include sodium channel modulation, apoptosis induction, cell cycle arrest, and autophagy inhibition.
• Ropivacaine acts through multiple targets/functions, necessitating further investigation.

Conclusions:

• Ropivacaine demonstrates significant potential as an anticancer agent and a chemosensitizer.
• Its multi-targeted action warrants further in-depth study for drug repurposing.
• Findings may guide the development of novel anticancer drugs through repurposing strategies.